BI
BVF Inc Portfolio holdings
AUM
$2.8B
This Quarter Return
+29.04%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$514M
AUM Growth
+$514M
(+6.7%)
Cap. Flow
-$62.2M
Cap. Flow
% of AUM
-12.1%
Top 10 Holdings %
Top 10 Hldgs %
73.17%
Holding
39
New
7
Increased
8
Reduced
6
Closed
8
Top Buys
Top Sells
| 1 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$71.2M |
| 2 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$17.2M |
| 3 |
Ligand Pharmaceuticals
LGND
|
$13.2M |
| 4 |
ARRY
Array Biopharma Inc
ARRY
|
$9.95M |
| 5 |
ProQR Therapeutics
PRQR
|
$9.44M |
Sector Composition
| 1 | Healthcare | 70.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
APTO
26
DELISTED
Aptose Biosciences, Inc.
APTO
| $986K | 0.19% | +166,664 | New | +$986K |
|
|
VXRT
27
DELISTED
Vaxart
VXRT
| $976K | 0.19% | 435,900 | – | – |
|
|
ANTH
28
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $884K | 0.17% | 559,624 | – | – |
|
|
SPHS
29
DELISTED
Sophiris Bio, Inc.
SPHS
| $573K | 0.11% | 1,060,283 +460,283 | +77% | +$249K |
|
30
Ardelyx
ARDX
$1.53B
| – | – | -453,541 | Closed | -$6.45M |
|
|
31
ProQR Therapeutics
PRQR
$237M
| – | – | -549,000 | Closed | -$9.44M |
|
|
PTN
32
DELISTED
Palatin Technologies
PTN
| – | – | -750,655 | Closed | -$698K |
|
33
uniQure
QURE
$896M
| – | – | -106,500 | Closed | -$981K |
|
|
RGLS
34
DELISTED
Regulus Therapeutics
RGLS
| – | – | -184,999 | Closed | -$1.26M |
|
|
TRVN
35
DELISTED
Trevena, Inc.
TRVN
| – | – | -1,118,743 | Closed | -$7.18M |
|
|
PRTK
36
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| – | – | -150,000 | Closed | -$304K |
|
|
RCPT
37
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| – | – | -1,146,300 | Closed | -$71.2M |
|